PARP-inhibitors in epithelial ovarian cancer: actual positioning and future expectations

European Medicines Agency

Source: Cancer Treatment Reviews - July 14, 2021 Category: Cancer & Oncology Authors: H élène Vanacker, Philipp Harter, Sana Intidhar Labidi-Galy, Susana Banerjee, Ana Oaknin, Domenica Lorusso, Isabelle Ray-Coquard Source Type: research